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CASE REPORT
Veno-venous extracorporeal membrane 
oxygenation in the management of refractory 
bilateral bronchial dehiscence after lung 
transplant: a case report
Makiko Tani*  
Abstract 
Background: Bronchial dehiscence is a life-threatening complication after lung transplant. If it is not treated by 
placement of stent or reanastomosis, the chance of survival will depend on the availability of a new graft. However, 
retransplant is not a practical management option in Japan, where waiting time for lung transplant is extensive. We 
described a case of refractory bilateral bronchial dehiscence managed by veno-venous extracorporeal oxygenation 
membrane (VV ECMO) while allowing the dehiscence to heal.
Case presentation: A 25-year-old man with idiopathic pulmonary arterial hypertension underwent a bilateral lung 
transplant. The patient developed bilateral bronchial dehiscence. Open reanastomosis was not successful, and air 
leakage recurred under low positive pressure ventilation. VV ECMO was established to maintain oxygenation with 
spontaneous breathing until both dehiscence were closed by adhesions.
Conclusion: In a patient with refractory bilateral bronchial dehiscence, VV ECMO may provide bronchial rest and 
serve as a bridge therapy to recovery.
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Background
Bronchial dehiscence is one possible anastomotic airway 
complication after lung transplant. Bronchial dehiscence 
has been reported in 1–10% of lung transplant recipients 
[1], but it is associated with high mortality [2]. Treatment 
options for bronchial dehiscence are placement of stents, 
surgical suture, pneumonectomy, and retransplant [3]. 
Indication of the options should be considered based on 
estimated effectiveness, operability, and availability for 
new lung graft.
Pulmonary infections after lung transplant predispose 
patients to bronchial dehiscence [3]. Impaired tissue 
oxygenation and carbon dioxide elimination because of 
pneumonia necessitate mechanical ventilation, which 
increases the risk of bronchial dehiscence.
Here, we report a case of bilateral bronchial dehiscence 
with pneumonia, in which none of the management 
options for bronchial dehiscence described above was 
effective or applicable. We utilized veno-venous extra-
corporeal membrane oxygenation (VV ECMO) until the 
dehiscence closed in order to prevent air leak and main-
tain oxygenation and ventilation.
Case presentation
We obtained a written informed consent from the patient 
for the publication of this case report.
A 25-year-old male with idiopathic pulmonary arte-
rial hypertension underwent double lung transplant. He 
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was extubated on postoperative day (POD) 4 unevent-
fully other than 2 days being febrile. However, CT scan 
on POD 6 revealed filtration in both lungs. We diagnosed 
the filtration as pneumonia due to Pseudomonas aergin-
osa, Enterobacter, and methicillin-resistant Staphylococ-
cus aureus, and administered antibiotics specific to the 
bacteria. On POD 17, a chest X-ray revealed right-sided 
pneumothorax, and a chest tube was inserted into the 
right chest cavity. A subsequent CT scan revealed bilat-
eral bronchial dehiscence (Fig. 1) and adhesion of pulmo-
nary arteries (PAs) into the bronchus.
The patient was transferred to the operating room for 
emergency surgical inspection. With ECMO on standby, 
general anesthesia was induced. The trachea was intu-
bated with a double lumen tube. Bronchoscopy was 
performed before surgery which revealed dehiscence of 
bilateral bronchial anastomosis.
Surgical inspection revealed both-sided bronchial 
dehiscence and adhesion of the left PA to the left bron-
chus. Due to a risk of PA penetration into the bronchus, 
the dehiscence could not be sutured circumferentially. 
Then, the dehiscence was repaired with partial suture 
combined with omentoplasty and thymus wrapping 
under mechanical ventilation. We did not establish 
ECMO or cardiopulmonary bypass due to concerns that 
bleeding from the PA could become uncontrollable due 
to anticoagulation. A tracheostomy was also performed 
at the end of the surgery. There was no pneumothorax or 
air leakage from the bilateral chest tubes.
After the surgery, we attempted to wean the patient 
from ventilator support to minimize positive pressure 
on the repair site. However, respiratory suppression by 
high dose sedatives (propofol 250 mg/h, morphine 6 
mg/h, and dexmedetomidine 0.5 mcg/kg/h) to prevent 
coughing and impaired oxygenation due to pneumonia 
necessitated positive airway ventilation (positive end-
expiratory pressure 3–5  cmH2O, pressure control 5–8 
 cmH2O) with inhaled nitric oxide. The patient spent 3 
days with no air leakage. On POD 21, massive air leak-
age appeared from both chest tubes under peak inspira-
tory pressure (PIP) 13  cmH2O. Ineffective ventilation due 
to air leakage as well as pneumonia deteriorated the gas 
exchange to  PaO2 70 mmHg,  PaCO2 100 mmHg  (FIO2 
1.0, positive end-expiratory pressure 8  cmH2O, PIP 15 
 cmH2O). Hypercarbia necessitated emergent installation 
of VV ECMO through both femoral veins, and positive 
airway ventilation was discontinued. The patient was 
assisted with VV ECMO while breathing spontaneously 
through the tracheostomy, resulting in improved gas 
exchange and cessation of air leakage.
Placement of stents and re-opening for exploration 
were management options for the dehiscence; however, 
we decided neither was indicated for the patient because 
of PA adhesion and concern of subsequent PA perfora-
tion into the bronchus. Retransplant for this patient was 
theoretically a treatment option; however, retransplant 
was not practical because of the paucity of lung donors 
in Japan.
During ECMO support, we tolerated partial flow 
(60–70% of total flow and 4L/min sweep gas) as to not 
administer excess volume and to keep the lungs dry. We 
also used high flow oxygen therapy  (FIO2 1.0 and oxygen 
flow rate 20 L/minute) for spontaneous breathing sup-
port and preventing lung collapse, and  PaO2 80s mmHg 
and  PaCO2 40s mmHg were maintained. In addition, 
activated clotting time (ACT) was controlled at approxi-
mately 150 seconds to prevent bleeding particularly from 
the anastomosis site and tracheostomy.
Under VV ECMO support, we provided conserva-
tive therapy for the patient. Intravenous morphine was 
Fig. 1 A, B Images of computed tomography scan performed 15 days after the transplantation showing bronchial dehiscence (red arrows), 
pneumothorax (black arrows), and associated pneumonia (blue arrow)
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continued for suppressing cough and avoiding high pres-
sure on the repair lesions. Instead, sputum was removed 
with bronchoscopy every four hours. We awakened the 
patient in the daytime and encouraged physical therapy 
to prevent muscle atrophy and improve pulmonary func-
tion. Antibiotics were continued for pneumonia.
On POD 29, improvement of bronchial dehiscence was 
confirmed by bronchoscopy and CT scan (Fig.  2A, B); 
however, bilateral pneumonia remained. After the pneu-
monia improved, the patient was successfully weaned 
from ECMO on POD 32, the twelfth day after ECMO 
installation. The patient could maintain oxygenation 
 (PaO2 81mmHg) and carbon dioxide removal  (PaCO2 
38mmHg) by high-flow oxygen therapy  (FIO2 0.9 and 
oxygen flow 20L/minute). ECMO circuit exchange was 
necessary twice due to blood clots within the artificial 
lung during the 12 days. However, the patient had neither 
embolic nor hemorrhagic complications. He was dis-
charged from the intensive care unit after 1 month.
Discussion
This is a case of bilateral bronchial dehiscence with res-
piratory failure which resolved after 12 days of VV 
ECMO support, despite the fact that the sites of dehis-
cence were not completely repaired surgically.
Management of patients with repaired bronchial dehis-
cence and respiratory failure is challenging because there 
is a management dilemma. Airway pressure should be 
minimized to protect repaired anastomosis, whereas 
adequate respiratory support is required to maintain 
oxygenation and ventilation. Implementing VV ECMO 
for patients with bronchial dehiscence has two ben-
efits: (1) Influence on the surgical repair of the bron-
chial dehiscence by inspiratory positive airway pressure 
can be reduced. Positive airway pressure decreases pul-
monary blood flow and worsens bronchial ischemia [4]. 
In addition, reduction of pulmonary shear stress has a 
protective effect on bronchial healing [5]. (2) Reduced 
oxygenation and carbon dioxide elimination induced by 
respiratory failure were substituted.
There is no clear consensus on treatment for bronchial 
dehiscence, and management practice depends on the 
severity of the dehiscence and associated complications 
[6]. For cases with large dehiscence or cases of failed stent 
placement, surgical repair is considered. However, surgi-
cal repair in such cases is difficult due to the presence of 
infection and ischemia, resulting in high failure rate and 
poor outcome [6, 7]. If the management mentioned above 
is not successful, allograft resection or re-transplant 
could be therapeutic options. In this case, these strategies 
were considered when air leakage recurred after surgical 
repair; however, neither strategy was adopted. The bron-
chial dehiscence was both-sided, and both grafts were 
affected by an infection. A one-sided allograft resection 
would not have been tolerable. Furthermore, the waiting 
time for a lung transplant did not depend on the alloca-
tion score in Japan, as the average waiting time was about 
900 days in Japan. Thus, emergency re-transplant was not 
a viable option.
For reviving the impaired allografts, management strat-
egy during ECMO support was critical. First, we set the 
lower ACT goal of heparinization for ECMO than the 
popular ACT range of 180-200 seconds with the aim of 
preventing hemorrhage [8]. Hemorrhage from anas-
tomosis and tracheostomy could be life-threatening in 
this case. Second, we started physical therapy while the 
patient was on ECMO support to improve respiratory 
function. There are some complications from physi-
cal therapy combined with ECMO, such as a decrease 
in peripheral oxygen saturation, cannula fracture, and 
obstructive thrombus in return cannula [9]; however, 
physical therapy together with ECMO is relatively safe 
Fig. 2 A, B The follow-up CT scan 12 days after the surgical repair revealing good healing of the bilateral dehiscence (red arrows)
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and effective for secretion clearance and pulmonary 
recovery [10, 11].
We did not implement VV ECMO during the surgical 
repair considering the risk of bleeding from the PA which 
was firmly adhered to the bronchus. We should have used 
VV ECMO right after the surgical repair was completed, 
an action that could have prevented recurrent air leakage 
which was induced by inspiratory airway pressure affect-
ing the reanastomosis.
Conclusion
Bronchial dehiscence after lung transplant is life-threat-
ening. In our case, VV ECMO provided bronchial rest 
and served as a bridge therapy to recovery.
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